医疗保健合同研究组织 (CRO) 服务市场基于(关键区域、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00010465
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Healthcare Contract Research Organizations (CRO) Services Market Report by 2031

Buy Now

医疗保健合同研究组织 (CRO) 服务市场规模预计将从 2023 年的 573.1 亿美元增至 2031 年的 1028.6 亿美元。预计 2023 年至 2031 年该市场的复合年增长率为 7.6%。全球不断增加的临床研究可能仍将是医疗保健合同研究组织 (CRO) 服务市场的主要趋势。  CRO) services market size projected to reach US$ 102.86 billion by 2031 from US$ 57.31 billion in 2023. The market is expected to register a CAGR of 7.6% in 2023–2031. The increasing clinical studies globally will likely remain a key healthcare contract research organization's (CRO) services market trend.  

 

医疗保健合同研究组织 (CRO) 服务市场分析

对新药需求的增加、慢性病患病率的增加以及临床试验资助计划的增加等因素推动了全球临床试验的数量。临床试验的管理需要扩展的研究设施、专用资源和充足的财务要求。临床试验的这些先决条件创造了一个富有成效的环境,有利于合同研究组织来执行临床研究。上述因素将推动预测期内的市场增长。

 

医疗保健合同研究组织 (CRO) 服务市场概述

制药和生物技术公司专注于研发活动,以创新慢性疾病的新分子和治疗平台。哮喘是全球儿童中最常见的慢性疾病,世界卫生组织估计全球约有 2.63 亿人患有哮喘。因此,慢性疾病的日益流行可能会导致新药物的开发,这将进一步加速医疗保健合同研究组织(CRO)服务市场的增长。

 

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

医疗保健合同研究组织 (CRO) 服务市场:

Healthcare Contract Research Organizations (CRO) Services Market: Strategic Insights

Healthcare Contract Research Organizations (CRO) Services Market

  • CAGR (2023 - 2031)
    7.6%
  • Market Size 2023
    US$ 57.31 Billion
  • Market Size 2031
    US$ 102.86 Billion

Key Players

  • Charles River Laboratories Inc.
  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Parexel International Corporation
  • Icon Plc.
  • Pra Health Sciences
  • Syneos Health
  • Medpace
  • Wuxi Apptec
  • PPD Inc

Regional Overview

  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

服务类型(早期开发、实验室服务、咨询服务、临床研究服务)
    治疗适应症(肿瘤、传染病、呼吸系统疾病、心血管疾病、神经系统疾病、其他)
      最终用户(医疗器械公司、制药和生物制药公司等)

        医疗保健合同研究组织 (CRO) 服务市场

        • 年均复合增长率(2023 - 2031)
          7.6%
        • 2023 年市场规模
          573.1 亿美元
        • 2031 年市场规模
          1028.6 亿美元

        市场动态

        增长动力
        • 增加外包活动有利于市场
        未来的趋势
        • 不断增长的生物仿制药和生物制剂市场
        机会
        • 增加临床研究

        关键人物;主力;重要一员

        • 查尔斯河实验室公司
        • IQVIA 公司
        • 美国实验室控股公司
        • 精锐国际公司
        • 图标公司。
        • 普拉健康科学
        • Syneos 健康
        • 医疗空间
        • 无锡药明康德
        • PPD公司

        Regional Overview

        • North America
        • Europe
        • Asia-Pacific
        • South and Central America
        • Middle East and Africa

        Market Segmentation

        Service Type
        • Early Phase Development
        • Laboratory Services
        • Consulting Services
        • Clinical Research Services
        Therapeutic Indication
        • Oncology
        • Infectious Diseases
        • Respiratory Diseases
        • Cardiovascular Diseases
        • Neurological Disorders
        • Others
        End User
        • Medical Device Companies
        • Pharmaceutical and Biopharmaceutical Companies
        • Others
        • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

         

        Healthcare Contract Research Organizations (CRO) Services Market Drivers and Opportunities

         

        Increasing Outsourcing Activities to Favor Market

        Many companies are establishing strategic partnerships with contract research organizations. For instance, in January 2020, Aragen Bioscience, Inc, a subsidiary of GVK BIO, one of the significant players in pre-clinical CRO, entered into a strategic collaboration with Serum Institute of India Pvt. Ltd. to accelerate the R&D of multiple stable cell lines under Serum’s HIV program. Moreover, In 2022, Labcorp spin off its CRO segment, named Fortrea, which stands to “forward trials with ease” will work as an independent publicly traded CRO, and provide drug and medical device services, including clinical trial management and commercialization offerings.

         

        Rising Biosimilars and Biologics Market – An Opportunity in Healthcare Contract Research Organizations (CRO) Services Market

        The biotechnology industry expands scientists' toolboxes, and the combination of basic research, translational studies, and clinical trials will continue to develop, investigate, and test additional compounds, techniques, and therapeutic pathways. Biotechnology is a strategic sector for China. The Made in China 2025 initiative aims to produce high-tech products, including innovative medicines. The plan introduced targets for Chinese pharmaceutical companies to spur biotechnology innovation and increase exports. Furthermore, these Asian countries use genomics, proteomics, and biomarker advancements for diagnostic and therapeutic applications. Therefore, the ongoing evolution of the biotechnology industry in developing regions will create opportunities for the biologics and biosimilars market in the coming years.

         

        Healthcare Contract Research Organizations (CRO) Services Market Report Segmentation Analysis

        Key segments contributing to the derivation of the Healthcare Contract Research Organizations (CRO) Services market analysis are service type, therapeutic indication, and end user.

        • Based on service type, the healthcare contract research organizations (CRO) services market is divided into early phase development, laboratory services, consulting services, and clinical research services. The clinical research services segment held a larger market share in 2023.
        •  Based on therapeutic indication, the market is segmented into oncology, infectious diseases, respiratory diseases, cardiovascular diseases, neurological disorders, and others. The others segment held a larger market share in 2023.
        • In terms of end user, the market is segmented into medical device companies, pharmaceutical and biopharmaceutical companies, and others. The pharmaceutical and biopharmaceutical companies segment dominated the market in 2023.

         

        Healthcare Contract Research Organizations (CRO) Services Market Share Analysis by Geography

        The geographic scope of the Healthcare Contract Research Organizations (CRO) Services market report is mainly divided into five regions: North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The healthcare contract research organizations (CRO) services market in North America is significant. In North America, the growth of the healthcare contract research organizations (CRO) services market is primarily driven by high regulatory standards followed by the pharmaceutical industry, an increasing number of clinical trials, and the rapid growth of the biosimilars and biologics market. Marge pharmaceutical companies are expected to grow R&D spending at 4% per annum, I.e., US$234 billion by 2025. Likewise, biotechnology R&D spending is forecast to grow up to 8% per annum. The above factors is expected to affect the healthcare contract research organizations (CRO) positively services market growth.

         

        Healthcare Contract Research Organizations (CRO) Services Market Report Scope

        Report AttributeDetails
        Market size in 2023US$ 57.31 Billion
        Market Size by 2031US$ 102.86 Billion
        Global CAGR (2023 - 2031)7.6%
        Historical Data2021-2022
        Forecast period2024-2031
        Segments CoveredBy Service Type
        • Early Phase Development
        • Laboratory Services
        • Consulting Services
        • Clinical Research Services
        By Therapeutic Indication
        • Oncology
        • Infectious Diseases
        • Respiratory Diseases
        • Cardiovascular Diseases
        • Neurological Disorders
        • Others
        By End User
        • Medical Device Companies
        • Pharmaceutical and Biopharmaceutical Companies
        • Others
        Regions and Countries CoveredNorth America
        • US
        • Canada
        • Mexico
        Europe
        • UK
        • Germany
        • France
        • Russia
        • Italy
        • Rest of Europe
        Asia-Pacific
        • China
        • India
        • Japan
        • Australia
        • Rest of Asia-Pacific
        South and Central America
        • Brazil
        • Argentina
        • Rest of South and Central America
        Middle East and Africa
        • South Africa
        • Saudi Arabia
        • UAE
        • Rest of Middle East and Africa
        Market leaders and key company profiles
        • Charles River Laboratories Inc.
        • IQVIA Inc.
        • Laboratory Corporation of America Holdings
        • Parexel International Corporation
        • Icon Plc.
        • Pra Health Sciences
        • Syneos Health
        • Medpace
        • Wuxi Apptec
        • PPD Inc
        • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

         

         

        Healthcare Contract Research Organizations (CRO) Services Market News and Recent Developments

        医疗保健合同研究组织 (CRO) 服务市场是通过收集初级和二级研究后的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。以下是创新、业务扩展和战略市场发展的列表:

        • 2021年6月,为制药和医疗器械行业提供全方位服务的合同研究组织(CRO)LINK Medical与安全和药物警戒组织的专家咨询和技术服务提供商Insife签署了联手合同。 (来源:LINK Medical,新闻稿)
        • 2020 年 4 月,PPD, Inc. 旗下业务 Accelerated Enrollment Solutions (AES) 推出了一项新计划,通过将临床试验患者从其他地方转移到 AES 的专用研究中心,帮助生物制药公司在全球 COVID-19 大流行期间保持业务连续性。冠状病毒危机影响的研究设施。 (来源:PPD, Inc,时事通讯)

         

        医疗保健合同研究组织 (CRO) 服务市场报告范围和可交付成果

        《医疗保健合同研究组织 (CRO) 服务市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

        • 医疗保健合同研究组织 (CRO) 服务市场规模以及全球、区域和国家层面涵盖范围内所有关键细分市场的预测
        • 市场动态,例如驱动因素、限制因素和关键机遇
        • 医疗保健合同研究组织 (CRO) 服务市场趋势
        • 详细的 PEST 和 SWOT 分析
        • 医疗保健合同研究组织 (CRO) 服务市场涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
        • 医疗保健合同研究组织 (CRO) 服务行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者和最新发展
        • 详细的公司简介

        Healthcare Contract Research Organizations (CRO) Services Market Report Scope

        Report Attribute Details
        Market size in US$ 57.31 Billion
        Market Size by US$ 102.86 Billion
        Global CAGR 7.6%
        Historical Data 2021-2022
        Forecast period 2024-2031
        Segments Covered By 服务类型(早期开发、实验室服务、咨询服务、临床研究服务)
        By 治疗适应症(肿瘤、传染病、呼吸系统疾病、心血管疾病、神经系统疾病、其他)
        By 最终用户(医疗器械公司、制药和生物制药公司等)
        Regions and Countries Covered 北美(美国、加拿大、墨西哥)
        • 北美(美国、加拿大、墨西哥)
        欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        Market leaders and key company profiles
      • Charles River Laboratories Inc.
      • IQVIA Inc.
      • Laboratory Corporation of America Holdings
      • Parexel International Corporation
      • Icon Plc.
      • Pra Health Sciences
      • Syneos Health
      • Medpace
      • Wuxi Apptec
      • PPD Inc
      • Report Coverage
        Report Coverage

        Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

        Segment Covered
        Segment Covered

        This text is related
        to segments covered.

        Regional Scope
        Regional Scope

        North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

        Country Scope
        Country Scope

        This text is related
        to country scope.

        The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

        1. Data Collection and Secondary Research:

        As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

        Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

        1. Primary Research:

        The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

        For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

        A typical research interview fulfils the following functions:

        • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
        • Validates and strengthens in-house secondary research findings
        • Develops the analysis team’s expertise and market understanding

        Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

        • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
        • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

        Below is the breakup of our primary respondents by company, designation, and region:

        Research Methodology

        Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

        1. Data Analysis:

        Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

        • Macro-Economic Factor Analysis:

        We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

        • Country Level Data:

        Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

        • Company Profile:

        The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

        • Developing Base Number:

        Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

        1. Data Triangulation and Final Review:

        The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

        We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

        We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

        Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

        Related Reports